87 related articles for article (PubMed ID: 11999341)
1. Immunoregulatory activities of lactoferrin in the delayed type hypersensitivity in mice are mediated by a receptor with affinity to mannose.
Zimecki M; Kocieba M; Kruzel M
Immunobiology; 2002 Mar; 205(1):120-31. PubMed ID: 11999341
[TBL] [Abstract][Full Text] [Related]
2. The adjuvant activity of lactoferrin in the generation of DTH to ovalbumin can be inhibited by bovine serum albumin bearing alpha-D-mannopyranosyl residues.
Kocieba M; Zimecki M; Kruzel M; Actor J
Cell Mol Biol Lett; 2002; 7(4):1131-6. PubMed ID: 12511980
[TBL] [Abstract][Full Text] [Related]
3. Lactoferrin inhibits the effector phase of the delayed type hypersensitivity to sheep erythrocytes and inflammatory reactions to M. bovis (BCG).
Zimecki M; Machnicki M
Arch Immunol Ther Exp (Warsz); 1994; 42(3):171-7. PubMed ID: 7487348
[TBL] [Abstract][Full Text] [Related]
4. Effect of lactoferrin on the methotrexate-induced suppression of the cellular and humoral immune response in mice.
Artym J; Zimecki M; Kruzel ML
Anticancer Res; 2004; 24(6):3831-6. PubMed ID: 15736418
[TBL] [Abstract][Full Text] [Related]
5. Systemic or local co-administration of lactoferrin with sensitizing dose of antigen enhances delayed type hypersensitivity in mice.
Zimecki M; Kruzel ML
Immunol Lett; 2000 Nov; 74(3):183-8. PubMed ID: 11064098
[TBL] [Abstract][Full Text] [Related]
6. Lactoferrin as an Adjuvant for the Generation of Delayed Type Hypersensitivity to Orally Administered Antigen.
Zimecki M; Kruzel ML; Hwang SA; Wilk KM; Actor JK
Ann Clin Lab Sci; 2021 May; 51(3):359-367. PubMed ID: 34162566
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the human lactoferrin (HLF) cell line HLFK1, generated in CBA mice.
Kocieba M; Zimecki M; Chodaczek G
Cell Mol Biol Lett; 2003; 8(1):41-8. PubMed ID: 12655355
[TBL] [Abstract][Full Text] [Related]
8. A complex of lactoferrin with monophosphoryl lipid A is an efficient adjuvant of the humoral and cellular immune response in mice.
Chodaczek G; Zimecki M; Lukasiewicz J; Lugowski C
Med Microbiol Immunol; 2006 Dec; 195(4):207-16. PubMed ID: 16838169
[TBL] [Abstract][Full Text] [Related]
9. Lactoferrin immunomodulation of DTH response in mice.
Actor JK; Hwang SA; Olsen M; Zimecki M; Hunter RL; Kruzel ML
Int Immunopharmacol; 2002 Mar; 2(4):475-86. PubMed ID: 11962727
[TBL] [Abstract][Full Text] [Related]
10. Lactoferrin inhibits proliferative response and cytokine production of TH1 but not TH2 cell lines.
Zimecki M; Mazurier J; Spik G; Kapp JA
Arch Immunol Ther Exp (Warsz); 1996; 44(1):51-6. PubMed ID: 8874770
[TBL] [Abstract][Full Text] [Related]
11. Antibody to ovalbumin and delayed-type hypersensitivity to Candida albicans and mycobacteria in lactating Holstein cows using Quil A or Freund's complete adjuvant.
Heriazon A; Thompson KA; Wilkie BN; Mathes-Sears W; Quinton M; Mallard BA
Vet Immunol Immunopathol; 2009 Feb; 127(3-4):220-7. PubMed ID: 19054579
[TBL] [Abstract][Full Text] [Related]
12. Bovine lactoferrin can be taken up by the human intestinal lactoferrin receptor and exert bioactivities.
Lönnerdal B; Jiang R; Du X
J Pediatr Gastroenterol Nutr; 2011 Dec; 53(6):606-14. PubMed ID: 21832946
[TBL] [Abstract][Full Text] [Related]
13. Reconstitution of the cellular immune response by lactoferrin in cyclophosphamide-treated mice is correlated with renewal of T cell compartment.
Artym J; Zimecki M; Kruzel ML
Immunobiology; 2003; 207(3):197-205. PubMed ID: 12777061
[TBL] [Abstract][Full Text] [Related]
14. Lactoferrin stimulates killing and clearance of bacteria but does not prevent mortality of diabetic mice.
Zagulski T; Jarzabek Z; Zagulska A; Jaszczak M; Kochanowska IE; Zimecki M
Arch Immunol Ther Exp (Warsz); 2001; 49(6):431-8. PubMed ID: 11814237
[TBL] [Abstract][Full Text] [Related]
15. Regulation of delayed-type hypersensitivity. I. T suppressor cells for delayed-type hypersensitivity to sheep erythrocytes in mice.
Liew FY
Eur J Immunol; 1977 Oct; 7(10):714-8. PubMed ID: 303999
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of bovine cutaneous delayed-type hypersensitivity (DTH) to various test antigens and a mitogen using several adjuvants.
Hernández A; Yager JA; Wilkie BN; Leslie KE; Mallard BA
Vet Immunol Immunopathol; 2005 Mar; 104(1-2):45-58. PubMed ID: 15661330
[TBL] [Abstract][Full Text] [Related]
17. Cluster mannosides can inhibit mannose receptor-mediated tissue-type plasminogen activator degradation by both rat and human cells.
Noorman F; Barrett-Bergshoeff MM; Biessen EA; van de Bilt E; van Berkel TJ; Rijken DC
Hepatology; 1997 Nov; 26(5):1303-10. PubMed ID: 9362376
[TBL] [Abstract][Full Text] [Related]
18. Lactoferrin inhibits human papillomavirus binding and uptake in vitro.
Drobni P; Näslund J; Evander M
Antiviral Res; 2004 Oct; 64(1):63-8. PubMed ID: 15451180
[TBL] [Abstract][Full Text] [Related]
19. Delayed-type hypersensitivity initiation by early-acting cells that are antigen mismatched or MHC incompatible with late-acting, delayed-type hypersensitivity effector T cells.
Ptak W; Herzog WR; Askenase PW
J Immunol; 1991 Jan; 146(2):469-75. PubMed ID: 1987274
[TBL] [Abstract][Full Text] [Related]
20. Isotype-like suppression of T cell-mediated immunity in vivo. I. Delayed-type hypersensitivity specificity of T cell suppression induced by antigen-binding T cell factors that initiate contact sensitivity.
Ptak W; Bereta M; Ptak M; Askenase PW
J Immunol; 1986 Mar; 136(5):1554-63. PubMed ID: 2419404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
